Bringing the fundamentals into focus…
Back to Anbio Biotechnology
How Anbio Biotechnology stacks up
NNNN · against 178 other Healthcare companies of similar size
Profitability
95/ 100
Near the top of its peers.
Ranked #5 of 179 · scores higher than 97% of peers
Bars: peers in each 10-point band of the profitability score8 peers with a profitability score of 90–100, including NNNN · Click a bar to see the companies
Why profitability scores 95?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its operating margin, return on assets and return on invested capital, which are stronger than most Healthcare peers.
- a higher return on invested capital: stronger than 86% of peers. Return on invested capital: 20.4% vs peer median 4.7%
- a higher return on assets: stronger than 98% of peers. Return on assets: 21.2% vs peer median 1.7%
- a wider operating margin: stronger than 100% of peers. Operating margin: 66.7% vs peer median 7.1%
Metric by metric
Position: dot = NNNN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NNNN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 142 reported | 20.4% | -5.2% | 96% | 33% | |
| Operating marginHigher is better · 163 reported | 66.7% | -1.9% | 100% | 33% | |
| Return on assetsHigher is better · 183 reported | 21.2% | -2.4% | 98% | 33% | |
| Return on equityHigher is better · 170 reported | 27.0% | -9.8% | 93% | Context only | |
| Gross marginHigher is better · 193 reported | 87.2% | 41.4% | 88% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around NNNN| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 261M USD | 98 | 97 | |
| 2 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 356M AUD (≈$235M) | 97 | 81 | |
| 4 | 592M ILS (≈$160M) | 96 | 84 | |
| 5 | 301M USD | 95 | 67 | |
| 5 | 267M USD | 95 | 75 | |
| 5 | 157M USD | 95 | ||
| 8 | 256M USD | 92 | 80 | |
| 9 | 8.1B TWD (≈$251M) | 89 | 69 | |
| 9 | 1.3B BRL (≈$238M) | 89 | 77 | |
| 11 | 144.4B KRW (≈$104M) | 88 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score